allthingspath.com had a recent interesting post on 2 possible outcomes for anatomic pathology at some point in the future of anatomic pathology.  One scenario is related to whole slide imaging and the other one is related to in vivo...

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...

As we get ready to flip the calendars over to 2017, a year that seems almost made up from the time I was about 10 in 1980 thinking wasn’t even a real number. By now we were supposed to be flying around in our transport pods with flux...

If immunotherapy has the cancer community riveted on the treatment side, liquid biopsies are equally exciting on the diagnostics end. And IBM is bringing its research heft to bear on the world of liquid biopsy with an intent to build a...

Exciting news today from FDA with news of approval of first liquid biopsy test for use in non-small cell lung cancer.  The cobas EGFR test is already approved for use in formalin-fixed paraffin-embedded (FFPE) tissue. This new use is intended...

I think that liquid biopsy, that is, using urine or peripheral blood samples will revolutionize cancer care and pathology over time.  Right now testing may be more limited with limited clinical trials but over time I think liquid biopsy will...